TY - JOUR
T1 - Effect of broad-spectrum antibiotics on in vitro synthesis of DNA in the rabbit colon
AU - Alpers, David H.
AU - Grimme, Nancy
N1 - Funding Information:
Received for publication July 22, 1977, and in revised form December 30,1977. This work was supported in part by a grant from The Upjohn Company, Kalamazoo, Michigan, and by grant no. AM-14038 from the National Institutes of Health. We thank Ms. Pam Helms and Ms. Catherine Camp for secretarial assistance. Please address requests for reprints to Dr. David H. Alpers, Gastroenterology Division, \Vashington University School of Medicine, 660 South Euclid, St. Louis, Missouri 63110.
PY - 1978/6
Y1 - 1978/6
N2 - Rabbit colonic mucosa was cultured in vitro in the presence of broad-spectrum antibiotics. DNA synthesis, as determined by [3H]thymidine incorporation into DNA, was inhibited by clindamycin (32%) and tetracycline (28%). Penicillin G, ampicillin, and metronidazole had no effect. When bile acids were added to the incubation at a concentration of 10 mxr, the more lipophilic drug, lincomycin, inhibited DNA synthesis by 38% (cholic acid) and by 23% (chenic acid). Bile acids alone did not alter thymidine incorporation. Inhibition by clindamycin demonstrated a gradual dose-response curve, with inhibition first noted at about 20 JLg of antibiotic/rnl and maximal inhibition at 1,000 µg/ml. The more biologically active metabolite of clindamycin, N-demethylclindamycin, inhibited DNA synthesis at concentrations of as low as 10 µg/ml. The inhibition was reversible, and the drugs did not affect thymidine uptake, thymidine pool concentrations, or protein or mucopolysaccharide synthesis at concentrations of up to 300 µg/ml. These data demonstrate a direct but reversible toxic action on mammalian colonic mucosa by certain antibiotics implicated in the production of pseudomembranous colitis and are consistent with the hypothesis that such a toxic action may be one factor in the pathogenesis of antibiotic-associated colitis.
AB - Rabbit colonic mucosa was cultured in vitro in the presence of broad-spectrum antibiotics. DNA synthesis, as determined by [3H]thymidine incorporation into DNA, was inhibited by clindamycin (32%) and tetracycline (28%). Penicillin G, ampicillin, and metronidazole had no effect. When bile acids were added to the incubation at a concentration of 10 mxr, the more lipophilic drug, lincomycin, inhibited DNA synthesis by 38% (cholic acid) and by 23% (chenic acid). Bile acids alone did not alter thymidine incorporation. Inhibition by clindamycin demonstrated a gradual dose-response curve, with inhibition first noted at about 20 JLg of antibiotic/rnl and maximal inhibition at 1,000 µg/ml. The more biologically active metabolite of clindamycin, N-demethylclindamycin, inhibited DNA synthesis at concentrations of as low as 10 µg/ml. The inhibition was reversible, and the drugs did not affect thymidine uptake, thymidine pool concentrations, or protein or mucopolysaccharide synthesis at concentrations of up to 300 µg/ml. These data demonstrate a direct but reversible toxic action on mammalian colonic mucosa by certain antibiotics implicated in the production of pseudomembranous colitis and are consistent with the hypothesis that such a toxic action may be one factor in the pathogenesis of antibiotic-associated colitis.
UR - http://www.scopus.com/inward/record.url?scp=0018197867&partnerID=8YFLogxK
U2 - 10.1093/infdis/137.6.756
DO - 10.1093/infdis/137.6.756
M3 - Article
C2 - 659921
AN - SCOPUS:0018197867
SN - 0022-1899
VL - 137
SP - 756
EP - 763
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 6
ER -